SUNZEN Stock Forum

$SUNZEN (0148.BMS)$ 0 volume

$SUNZEN-WC (0148WC.BMS)$
The bird’s nest division has posted its first loss. Although the bird’s nest business is traditionally seasonal, this still requires caution. Have the Chinese people switched to eating durian instead of bird’s nest starting in May? Or have they not finished their bird’s nests from the New Year yet? Domestic sales are also not good and Sunzen was forced to write off inventory. Fortunately, such losses are usually one-time off。
The profits in the human health segment primari...

Support Level: RM0.305
Resistance: RM0.335, RM0.350
Selling pressure on SUNZEN had tested the RM0.305 region, which had since rebounded strongly to the current RM0.330 level. We see a potential upward movement to challenge the RM0.335 and RM0.350 levels ahead, indicating a strong buying interest piqued by successful support level tests. Remain BUY for SUNZEN ahead.
$SUNZEN (0148.BMS)$

$SUNZEN-WC (0148WC.BMS)$
I heard that the bird’s nest farming industry is under pressure, with the price of the highest quality bird’s nests dropping from RM3300/kg in April to RM2400. This is reportedly due to crackdowns on smuggling by Chinese customs. Processing costs for bird’s nests have decreased by 25%. Assuming an export volume of 2600 kg over three months, Sunzen’s profits for June to September could theoretically increase by RM2 million. Additionally, the animal division has saved a mill...

$SUNZEN (0148.BMS)$ I guess the big boss has finished selling his/her stake.
Time for some news to trigger the spike, perhaps the QR?

$SUNZEN (0148.BMS)$
After the closure of the animal health department, how will these two properties, be handled? The report shows the valuation price in 2018, and now the property prices have increased even further.  will they sell the property and inject the money to finsource or use it for M&A？

$SUNZEN (0148.BMS)$ first outflow since a month ago

$SUNZEN (0148.BMS)$
2.6% of cw has been converted to ordinary shares in 2 months, bringing RM 1.9million cash to sunzen. the intention to reach 500 million capital is very obvious, they will use this money to carry another M&A , since floating cw getting lesser, i guess cw will move faster in the future.

Sunzen Biotech (KLSE: 0148) is poised for a breakout for the continued uptrend beyond RM0.350, the key resistance level for the company. Both MA20/50 showed positive strengths with reduced selling pressure. Key support remained at RM0.345, which was formed after multi tests on the consolidation phase. Maintain BUY for Sunzen Biotech.
Support: RM0.345, RM0.320
Resistance: RM0.350, RM0.370
$SUNZEN (0148.BMS)$